share_log

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

NexImmune | 4：持股變動聲明-高管 Jones Kristi
美股SEC公告 ·  06/14 07:59
牛牛AI助理已提取核心訊息
NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.
NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.
NexImmune, Inc.總裁兼首席執行官Kristi Jones於2024年6月11日完成了對公司股票的購買。交易涉及以每股0.01美元的價格收購1股NexImmune的A系列優先股。交易後，Jones直接擁有1股股權。該交易反映了該執行官對公司的信心，並向投資者發出了潛在未來業績的信號。
NexImmune, Inc.總裁兼首席執行官Kristi Jones於2024年6月11日完成了對公司股票的購買。交易涉及以每股0.01美元的價格收購1股NexImmune的A系列優先股。交易後，Jones直接擁有1股股權。該交易反映了該執行官對公司的信心，並向投資者發出了潛在未來業績的信號。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。